Naringin suppresses the development of glioblastoma by inhibiting FAK activity.
Li J, Dong Y, Hao G, Wang B, Wang J, Liang Y, Liu Y, Zhen E, Feng D, Liang G.
Li J, et al. Among authors: liang g, liang y.
J Drug Target. 2017 Jan;25(1):41-48. doi: 10.1080/1061186X.2016.1184668. Epub 2016 May 18.
J Drug Target. 2017.
PMID: 27125297